The Stem Cell Institute

The Stem Cell Institute The Stem Cell Institute are leaders in the successful treatment of human diseases and sports injuries with proprietary Golden Cells™ adult stem cells.

Stem Cell Institute is the one of the world’s premier adult stem cell therapy and research centers. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells and allogeneic human umbilical cord tissue-derived mesenchymal stem cells to treat: multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, autoimmune diseases, cerebral palsy and autism. To-date, we’ve treated over 10,000 patients. Two single-patient Duchenne’s muscular dystrophy clinical trials using our technology for harvesting and processing mesenchymal stem cells from human umbilical cord tissue received Investigational New Drug (IND) designations from the US FDA (IND 16026 DMD Single Patient). Since then, we have published phase I/II clinical trials in peer-reviewed scientific journals for multiple sclerosis and autism. We are completing another trial for rheumatoid arthritis and plan to publish the results in late 2020 or early 2021.

06/03/2026

Catherine came to us navigating the complex challenges of multiple autoimmune conditions, including Celiac disease, thyroid disorders, and lupus activity. Her journey took a turning point when she arrived at Stem Cell Institute, where the use of Golden Cells™ led to a systematic turnaround in her health.

The brain fog lifted, her energy surged, and her daily life regained its balance. As Catherine shares, her "brain turned back on," allowing her to manage work and home tasks with a clarity she thought was gone.

Your path toward progress starts with a medical evaluation. Apply today to see if our specialized protocols are the right fit for your journey.

https://loom.ly/fzTrbQg

05/03/2026

In this video, Dr. Neil Riordan, PA, PhD, discusses how mesenchymal stem cells (MSCs), including those derived from umbilical cord tissue, may help support immune balance in autoimmune conditions. He explains how these cells release bioactive factors that can influence inflammatory processes and assist the body’s natural repair mechanisms.

Rather than broadly suppressing immune function, Dr. Riordan describes an approach focused on helping regulate immune activity and promote overall systemic balance.

Find Out if You are a Candidate: Ready to see if MSC therapy is the right fit for your health journey? Complete our secure online application to have our medical team review your history and determine your eligibility for treatment - https://loom.ly/fzTrbQg

04/03/2026

March is National Autoimmune Awareness Month, a time to recognize the millions living with conditions where the immune system mistakenly attacks the body’s own healthy tissues. Traditional treatment approaches for autoimmune conditions often rely on long-term immunosuppressive medications, which may carry significant side effects for some patients. Regenerative medicine is being explored as a research-backed approach focused on modulating the immune response and supporting the body’s natural repair mechanisms.

At the Stem Cell Institute, our protocols utilize specially selected Golden Cells™ to help modulate the immune system and and support the healing and regeneration of damaged tissues, without suppressing the body’s overall ability to fight off disease. Many of our patients have reported life-changing results, from regaining the strength to perform daily tasks like preparing their own food to finding a renewed sense of independence and physical vitality.

If you or a loved one are searching for a way to move beyond merely managing symptoms and want to explore the potential of stem cell therapy, our medical team is ready to review your case. At Stem Cell Institute in Panama City, we provide a world-class, professional experience designed to support you every step of your health journey so you can focus on what matters most: improving your quality of life. Take the first step this National Autoimmune Awareness Month by applying at:

https://loom.ly/fzTrbQg

03/03/2026

"This doesn't happen very often..."

When Robin’s ENT at home saw her results after stem cell treatment, she was "gobsmacked." Robin came to Stem Cell Institute in Panama seeking relief from Sjögren's syndrome, and she left with a transformed quality of life. From the elimination of joint pain and neuropathy to the halting of her autoimmune-related hearing loss, she is grateful for every gain she's experienced through stem cell treatment.

Ready to see if stem cell therapy is right for you? Apply today:

https://loom.ly/fzTrbQg

02/03/2026

❌ Myth: The more cells you inject, the better the result.

✅ Fact: More is not always better. Clinical experience suggests that many treatments fall within a therapeutic “sweet spot,” often around 120–140 million cells, depending on the condition and method of delivery. Higher doses are not always more effective and must be evaluated carefully.

Our treatment protocols are based on extensive scientific research to ensure the best chance for positive outcomes. When choosing a stem cell clinic for treatment, do your research to ensure you receive quality cells over a high quantity.

Find out more at:

https://loom.ly/n6Y3hXA

20/02/2026

Travis’s mother was "constantly searching" for a breakthrough to help her son navigate the complexities of autism. That search found a turning point at Stem Cell Institute, where the introduction of Golden Cells™ led to a life-changing transformation.

The barriers to connection fell away as Travis "woke up" socially, moving from being "zoned out" to graduating high school and becoming conversational. As Bonita shares, the results have been "almost a miracle" for their family.

Your journey toward progress starts with a medical evaluation. Apply today to see if your child is a candidate for our specialized protocols at https://loom.ly/fzTrbQg

08/02/2026

It’s Heart Failure Awareness Week. Is it time for a new approach in treatment?

Heart failure affects millions, and while there is currently no cure, we are dedicated to providing a path toward a better quality of life. At the Stem Cell Institute, we use our specially selected Golden Cells™—robust, umbilical cord-derived mesenchymal stem cells—to help stimulate the body’s natural regenerative processes.

Unlike other methods, our therapy:
- Requires no invasive bone marrow or fat harvesting
- Uses "immune-privileged" cells (no rejection risk)
- Focuses on reducing inflammation and supporting heart muscle repair

It’s time to move beyond managing symptoms and start focusing on recovery. Find out if stem cell therapy is right for you. Submit your application at https://loom.ly/fzTrbQg

06/02/2026

Jay was diagnosed with heart failure following a severe COVID-19 hospitalization that required three months on a ventilator. His heart function was critical, with an ejection fraction measured at only 15%, compared to the normal range of 60% to 70%.

He traveled to the Stem Cell Institute in Panama after researching the work of founder Dr. Neil Riordan. Since receiving treatment, Jay has seen a marked improvement in his cardiac health and physical capability:

- His ejection fraction increased from 15% to over 35%.

- His resting heart rate has decreased and pulse ox levels and oxygen saturation have improved.

- He reports significantly better stamina and much faster recovery times during exercise.

For Jay, the treatment has been an essential component in his recovery, significantly helping him reclaim his quality of life.

Find out if you are a candidate for treatment. Start your medical evaluation by applying today to see if stem cell therapy is right for you: https://loom.ly/fzTrbQg

Today is   — a day to recognize the millions of people living with rheumatoid arthritis and the daily challenges of chro...
02/02/2026

Today is — a day to recognize the millions of people living with rheumatoid arthritis and the daily challenges of chronic joint pain and inflammation.

As Dr. Neil Riordan explains in A Rising Tide, most standard treatments for rheumatoid arthritis focus on suppressing the immune system to ease symptoms. While these approaches can bring temporary relief, they may not address the underlying tissue damage within the joints.

Dr. Riordan’s research has explored how umbilical cord–derived mesenchymal stem cells (MSCs) may help regulate immune activity and support cartilage regeneration. These cells have been studied for their ability to release bioactive factors that can reduce inflammation and promote the body’s natural repair processes.

See if you qualify for treatment. Submit an application at https://loom.ly/fzTrbQg

Dirección

BICSA Financial Center 63rd Fl
Panama City

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando The Stem Cell Institute publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Contacto El Consultorio

Enviar un mensaje a The Stem Cell Institute:

Compartir

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Stem Cell Institute is the one of the world’s premier adult stem cell therapy and research centers. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells and allogeneic human umbilical cord tissue-derived mesenchymal stem cells to treat: multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, autoimmune diseases, cerebral palsy and autism. To-date, we’ve treated over 10,000 patients.

Two single-patient Duchenne’s muscular dystrophy clinical trials using our technology for harvesting and processing mesenchymal stem cells from human umbilical cord tissue received Investigational New Drug (IND) designations from the US FDA (IND 16026 DMD Single Patient).

Since then, we have published phase I/II clinical trials in peer-reviewed scientific journals for multiple sclerosis and autism. We are completing another trial for rheumatoid arthritis and plan to publish the results in late 2020 or early 2021.